|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: Depo-Provera and osteoporosis--Monitoring long-term use?From: ainsron (ainsron@sbcglobal.net)Mon Jan 24 09:56:37 2005
However, since it is now there and we have to deal with it, what are others doing? 1. Sending the information to all patients who are currently on Depo Provera? 2. Sending the information to all patients who have ever taken Depo Provera? 3. Giving the information to all patients when they come in for their shots? 4. Nothing 5. Other .. Ronald E. Ainsworth -----Original Message----- From: Braun, R. Daniel [mailto:ob-gyn-l@obgyn.net] On Behalf Of Braun, R. Daniel Sent: Sunday, January 23, 2005 6:03 PM To: Multiple recipients of list OB-GYN-L Subject: Re: Depo-Provera and osteoporosis--Monitoring long-term use? The FDA's CYA response to The Vioxx fiasco. A totally inapropriate use of the BLACK BOX. -----Original Message----- From: ob-gyn-l@obgyn.net on behalf of Betsy Hyde Sent: Fri 1/21/2005 9:59 PM To: Multiple recipients of list OB-GYN-L Cc: Subject: Re: Depo-Provera and osteoporosis--Monitoring long-term use? here's the FDA Statement. My earlier post was not entirely correct....close, but not exactly it. http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01325.html Betsy Hyde CNM Branford, CT
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Thu Oct 2 04:47:39 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.